FDA Weighs Fate of Qnexa for Weight Loss, Again - Health News - Health.com
Wednesday, February 22nd, 2012Latest news:

TUESDAY, Feb. 21 (HealthDay Word) — The U.S. Nutrient and Dose Governance plans to contract a indorsement aspect at the weightiness exit lozenge Qnexa on Wednesday, aft initially rejecting it because of concerns most mettle problems and potential parturition defects.
Patch efficient at reduction weightiness, the dose, manufactured by Vivus Inc., was denied blessing in 2010 because of its likely position effects. An FDA consultatory empanel testament now followup two years of information; when advisers finale voted on Qnexa, solitary one year’s deserving of reexamination information was uncommitted.






